Lv1
56 积分 2022-07-29 加入
Understanding and overcoming multidrug resistance in cancer
1个月前
已完结
Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
3个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
4个月前
已完结
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
4个月前
已完结
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
5个月前
已完结
Widaplik: A Fixed-Dose Triple Combination for Initial Hypertension Therapy
6个月前
已关闭
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers
6个月前
已完结
皖公网安备34019202002308
